Zobrazeno 1 - 10
of 1 251
pro vyhledávání: '"T Schweizer"'
Autor:
R Meyer, M Ramos, M Lin, T Schweizer, Z Gold, D Ramos, S Shirazi, G Kandlikar, W Kwan, E Curd, A Freise, J Parker, J Sexton, R Wetzer, N Pentcheff, A Wall, L Pipes, A Garcia-Vedrenne, M Mejia, T Moore, C Orland, K Ballare, A Worth, E Beraut, E Aronson, R Nielsen, H Lewin, P Barber, J Wall, N Kraft, B Shapiro, R Wayne
Publikováno v:
California Agriculture, Vol 75, Iss 1 (2021)
Climate change is leading to habitat shifts that threaten species persistence throughout California's unique ecosystems. Baseline biodiversity data would provide opportunities for habitats to be managed under short-term and long-term environmental ch
Externí odkaz:
https://doaj.org/article/7edfd7affee94a01a458314ec7fe752f
Autor:
Mark C. Markowski, Hao Wang, Angelo M. De Marzo, Michael T. Schweizer, Emmanuel S. Antonarakis, Samuel R. Denmeade
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 112-115 (2022)
Bipolar androgen therapy (BAT) relies on oscillating levels of serum testosterone as a way to treat patients with metastatic castration-resistant prostate cancer (mCRPC). Aggressive-variant prostate cancers typically require combination chemotherapy
Externí odkaz:
https://doaj.org/article/4bc2a24fd1db4ec6b43aeedc41d28c67
Autor:
Navonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, Ilsa Coleman, Gavin Ha, Lisa S. Ang, Emily A. Kohlbrenner, Sander B. Frank, Talina A. Nunez, Stephen J. Salipante, Eva Corey, Colm Morrissey, Eliezer Van Allen, Michael T. Schweizer, Michael C. Haffner, Radhika Patel, Brian Hanratty, Jared M. Lucas, Ruth F. Dumpit, Colin C. Pritchard, Robert B. Montgomery, Peter S. Nelson
Publikováno v:
JCI Insight, Vol 6, Iss 23 (2021)
Cancers with homology-directed DNA repair (HRR) deficiency exhibit high response rates to poly(ADP-ribose) polymerase inhibitors (PARPi) and platinum chemotherapy. Though mutations disrupting BRCA1 and BRCA2 associate with HRR deficiency (HRRd), patt
Externí odkaz:
https://doaj.org/article/e560f44694e145f28e8ec0e2865f09db
Autor:
Emerson A. Lim, Michael T. Schweizer, Kim N. Chi, Rahul Aggarwal, Neeraj Agarwal, James Gulley, Edward Attiyeh, James Greger, Shujian Wu, Pharavee Jaiprasart, John Loffredo, Nibedita Bandyopadhyay, Hong Xie, Aaron R. Hansen
Publikováno v:
Clinical Genitourinary Cancer. 21:366-375
Autor:
Laura S. Graham, Michael C. Haffner, Erolcan Sayar, Agnes Gawne, Michael T. Schweizer, Colin C. Pritchard, Ilsa Coleman, Peter S. Nelson, Evan Y. Yu
Publikováno v:
The Prostate. 83:641-648
Autor:
Michael T, Schweizer, Lawrence, True, Roman, Gulati, Yibai, Zhao, William, Ellis, George, Schade, Bruce, Montgomery, Sonia, Goyal, Katie, Nega, Alexander K, Hakansson, Yang, Liu, Elai, Davicioni, Kenneth, Pienta, Peter S, Nelson, Daniel, Lin, Jonathan, Wright
Publikováno v:
Journal of Urology. 209:354-363
Active surveillance is a safe and effective strategy for men with lower-risk prostate cancer who want to avoid local therapy; however, many patients on active surveillance progress to active treatment (eg, prostatectomy or radiation). We hypothesized
Autor:
Laura S Graham, Bruce Montgomery, Heather H Cheng, Evan Y Yu, Peter S Nelson, Colin Pritchard, Stephanie Erickson, Ajjai Alva, Michael T Schweizer
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233260 (2020)
BACKGROUND:While response rates to anti-PD1 therapy are low in unselected metastatic castration resistant prostate cancer (mCRPC) patients, those with inactivating mutations in mismatch repair (MMR) genes (i.e. MMR deficiency; MMRd) or microsatellite
Externí odkaz:
https://doaj.org/article/72aa76cc3eb9475eb65eaa44e2277623
Autor:
Alexander S Carlson, Rigo I Acevedo, Daniel M Lim, Roman Gulati, Agnes Gawne, Alexandra O Sokolova, Heather H Cheng, Peter S Nelson, R Bruce Montgomery, Evan Y Yu, Michael T Schweizer
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239686 (2020)
IntroductionA significant proportion of patients with metastatic castration-resistant prostate cancer (mCRPC) harbor mutations in homologous recombination (HR) repair genes, with some of these mutations associating with increased tumor susceptibility
Externí odkaz:
https://doaj.org/article/f6c10cf143e14114ba66811e4329fc74
Autor:
Jennifer A. Hempelmann, Christina M. Lockwood, Eric Q. Konnick, Michael T. Schweizer, Emmanuel S. Antonarakis, Tamara L. Lotan, Bruce Montgomery, Peter S. Nelson, Nola Klemfuss, Stephen J. Salipante, Colin C. Pritchard
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-7 (2018)
Abstract Background Microsatellite instability (MSI) is now being used as a sole biomarker to guide immunotherapy treatment for men with advanced prostate cancer. Yet current molecular diagnostic tests for MSI have not been evaluated for use in prost
Externí odkaz:
https://doaj.org/article/b188986515774b1cb558720c61fd6f1d
Autor:
Hauke Hund, Reto Wettstein, Christopher Hampf, Martin Bialke, Maximilian Kurscheidt, Simon T. Schweizer, Christoph Zilske, Simon Mödinger, Christian Fegeler
Publikováno v:
Caring is Sharing – Exploiting the Value in Data for Health and Innovation ISBN: 9781643683881
Availability and accessibility are important preconditions for using real-world patient data across organizations. To facilitate and enable the analysis of data collected at a large number of independent healthcare providers, syntactic- and semantic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8d144e0aa9daef3e227cd27c842fd1a
https://doi.org/10.3233/shti230066
https://doi.org/10.3233/shti230066